According to VBI Vaccines 's latest financial reports the company's current EPS (TTM) is -12,56 โฌ. In 2022 the company made an earnings per share (EPS) of -12,00 โฌ a decrease over its 2021 EPS that were of -7,38 โฌ.
Year | EPS | Change |
---|---|---|
2023 (TTM) | -13,01 โฌ | 8.37% |
2022 | -12,00 โฌ | 62.69% |
2021 | -7,38 โฌ | 28.57% |
2020 | -5,74 โฌ | -53.33% |
2019 | -12,29 โฌ | -53.61% |
2018 | -26,50 โฌ | 10.23% |
2017 | -24,04 โฌ | 22.22% |
2016 | -19,67 โฌ | -94.55% |
2015 | -360,65 โฌ | 728.93% |
2014 | -43,51 โฌ | 92.1% |
2013 | -22,65 โฌ | -66.24% |
2012 | -67,09 โฌ | -77.97% |
2011 | -304,57 โฌ | 217.82% |
2010 | -95,83 โฌ | 954.43% |
2009 | -9,09 โฌ | -2273.56% |
2008 | 0,42 โฌ | -209.82% |
2007 | -0,38 โฌ | -42.44% |
2006 | -0,66 โฌ | -82.2% |
2005 | -3,72 โฌ | 2797.22% |
2004 | -0,13 โฌ | -41.9% |
2003 | -0,22 โฌ | -99.17% |
2002 | -26,73 โฌ | 8.12% |
2001 | -24,72 โฌ |